Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Echinatine
2. Indicine
3. Indicine Pyrrolizidine
4. Indicine, (1r-(1alpha,7(2s*,3r*),7abeta))-isomer
5. Indicine, (1r-(1alpha,7(2s*,3s*),7abeta))-isomer
6. Indicine, (1s-(1alpha,7(2r*,3r*),7aalpha))-isomer
7. Indicine, (1s-(1alpha,7(2r*,3s*),7aalpha))-isomer
8. Rinderine
1. 10285-07-1
2. (+)-lycopsamine
3. Ccirs 9199
4. Uer4et3ohi
5. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, ((1r,7ar)-2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (2s,3s)-
6. Ccris 9199
7. Unii-uer4et3ohi
8. 9-viridiflorylretronecine
9. Lycopsamine, Hplc Grade
10. 3'-epi-intermedine
11. (1r-(1alpha,7(2s*,3s*),7abeta))-(2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl 2,3-dihydroxy-2-(1-methylethyl)butanoate
12. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (1r-(1alpha,7(2s*,3s*),7abeta))-
13. Chebi:6598
14. Dtxsid60145542
15. Mfcd09260181
16. [(7r,8r)-7-hydroxy-5,6,7,8-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
17. Hy-124916
18. Retronecine 9-((-)-viridiflorate)
19. Cs-0089560
20. J-000819
21. Q27107262
22. ((1r,7ar)-1-hydroxy-2,3,5,7a-tetrahydro-1h-pyrrolizin-7-yl)methyl (2s,3s)-2,3-dihydroxy-2-isopropylbutanoate
23. [(1r,7ar)-1-hydroxy-2,3,5,7a-tetrahydro-1h-pyrrolizin-7-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
24. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (1r-(1.alpha.,7(2s*,3s*),7a.beta.))-
| Molecular Weight | 299.36 g/mol |
|---|---|
| Molecular Formula | C15H25NO5 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 299.17327290 g/mol |
| Monoisotopic Mass | 299.17327290 g/mol |
| Topological Polar Surface Area | 90.2 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 436 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Lycopsamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lycopsamine manufacturer or Lycopsamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lycopsamine manufacturer or Lycopsamine supplier.
PharmaCompass also assists you with knowing the Lycopsamine API Price utilized in the formulation of products. Lycopsamine API Price is not always fixed or binding as the Lycopsamine Price is obtained through a variety of data sources. The Lycopsamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lycopsamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lycopsamine, including repackagers and relabelers. The FDA regulates Lycopsamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lycopsamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lycopsamine supplier is an individual or a company that provides Lycopsamine active pharmaceutical ingredient (API) or Lycopsamine finished formulations upon request. The Lycopsamine suppliers may include Lycopsamine API manufacturers, exporters, distributors and traders.
Lycopsamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lycopsamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lycopsamine GMP manufacturer or Lycopsamine GMP API supplier for your needs.
A Lycopsamine CoA (Certificate of Analysis) is a formal document that attests to Lycopsamine's compliance with Lycopsamine specifications and serves as a tool for batch-level quality control.
Lycopsamine CoA mostly includes findings from lab analyses of a specific batch. For each Lycopsamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lycopsamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Lycopsamine EP), Lycopsamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lycopsamine USP).
